These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11129 related articles for article (PubMed ID: 10751032)

  • 1. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel.
    Constantinides PP; Lambert KJ; Tustian AK; Schneider B; Lalji S; Ma W; Wentzel B; Kessler D; Worah D; Quay SC
    Pharm Res; 2000 Feb; 17(2):175-82. PubMed ID: 10751032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system.
    Kan P; Chen ZB; Lee CJ; Chu IM
    J Control Release; 1999 Apr; 58(3):271-8. PubMed ID: 10099152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
    Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.
    Lo ST; Stern S; Clogston JD; Zheng J; Adiseshaiah PP; Dobrovolskaia M; Lim J; Patri AK; Sun X; Simanek EE
    Mol Pharm; 2010 Aug; 7(4):993-1006. PubMed ID: 20481608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
    Sharma US; Balasubramanian SV; Straubinger RM
    J Pharm Sci; 1995 Oct; 84(10):1223-30. PubMed ID: 8801338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.
    Fan T; Takayama K; Hattori Y; Maitani Y
    Pharm Res; 2004 Sep; 21(9):1692-7. PubMed ID: 15497698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation.
    Zhang XN; Tang LH; Gong JH; Yan XY; Zhang Q
    PDA J Pharm Sci Technol; 2006; 60(2):89-94. PubMed ID: 16696191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
    Kim JE; Park YJ
    Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
    Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
    Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nanoparticle formulation for sustained paclitaxel delivery.
    Trickler WJ; Nagvekar AA; Dash AK
    AAPS PharmSciTech; 2008; 9(2):486-93. PubMed ID: 18431660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability.
    Han J; Davis SS; Papandreou C; Melia CD; Washington C
    Pharm Res; 2004 Sep; 21(9):1573-80. PubMed ID: 15497682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants.
    Lo JT; Chen BH; Lee TM; Han J; Li JL
    J Pharm Sci; 2010 May; 99(5):2320-32. PubMed ID: 19894274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.
    Xia XJ; Guo RF; Liu YL; Zhang PX; Zhou CP; Jin DJ; Wang RY
    Chem Pharm Bull (Tokyo); 2011; 59(3):321-6. PubMed ID: 21372412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
    Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
    Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol).
    Lundberg BB
    J Pharm Pharmacol; 1997 Jan; 49(1):16-21. PubMed ID: 9120763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
    Jain V; Nath B; Gupta GK; Shah PP; Siddiqui MA; Pant AB; Mishra PR
    J Pharm Pharmacol; 2009 Mar; 61(3):303-10. PubMed ID: 19222902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
    Ibrahim NK; Desai N; Legha S; Soon-Shiong P; Theriault RL; Rivera E; Esmaeli B; Ring SE; Bedikian A; Hortobagyi GN; Ellerhorst JA
    Clin Cancer Res; 2002 May; 8(5):1038-44. PubMed ID: 12006516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 557.